Search - tctmd.com

Displaying 221 - 240 of 452

Sort: Relevancy | Date

News Features TCT 2014

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Todd Neale

October 24, 2014

News Daily News

Preexisting—But Not New-Onset—A-fib Predicts Worse Long-term Outcomes After TAVR

October 17, 2014

News Daily News

La FA Preexistente, No de Reciente Aparición, Predice Peores Resultados a Largo Plazo Post-TAVR

October 17, 2014

News Daily News

Preexisting Thrombocytopenia Worsens Complications After TAVR

L.A. McKeown

October 16, 2014

News Daily News

La Trombocitopenia Preexistente Empeora las Complicaciones Post-TAVR

L.A. McKeown

October 16, 2014

News Daily News

PARTNER Data Provide More Evidence of Mortality Impact of Post-TAVR Regurgitation

October 10, 2014

News Daily News

Datos del PARTNER ofrecen Más Evidencias del Impacto de la Mortalidad sobre la Regurgitación Post-TAVR

October 10, 2014

Presentation TCT 2014

The Percutaneous Transfemoral Approach Is Preferred in Most Patients Case Selection, Technique, and Outcomes!

Presenter: Mathew Williams

September 16, 2014

Presentation TCT 2014

TCT 701: A Multidisciplinary, Multimodality but Minimalist (3M) Approach to Transfemoral Transcatheter Aortic Valve Replacement Facilitates Safe Next-Day Discharge Home in High-Risk Patients: 1-Year Follow-up

Presenter: Danny Dvir

September 16, 2014

Presentation TCT 2014

The Cost of TAVR: Association Between Length of Stay and the Cost of Transfemoral Transcatheter Aortic Valve Replacement in Medicare Patients

Presenter: Christopher Meduri

September 16, 2014

Presentation TCT 2014

Landscape Highlights of New Transfemoral Access-Closure Devices

Presenter: Alexandre Abizaid

September 15, 2014

News Conference News TCT 2014

Capture Devices Hold Promise for Decreasing TAVR-Related Stroke

September 15, 2014

Presentation TCT 2014

Case #2: Transfemoral TAVR for Bicuspid Aortic Valve Stenosis Using a Second-Generation Device

Presenter: Graham A. Cassel, Hans R. Figulla, Greg L. Kaluza, Jochen Wöhrle, Peter Boekstegers

September 14, 2014

News Conference News TCT 2014

TCT Course Director Outlines Current TAVR Controversies

September 14, 2014

News Conference News TCT 2014

Registry Data Show Promise of Valve-in-Valve TAVR in High-Risk Patients

September 14, 2014

Presentation TCT 2014

TCT 687: One-Year Outcomes of Transfemoral Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Intermediate Surgical Risk: The Italian OBSERVANT Study

Presenter: Martin B. Leon, Neil E. Moat, Ariel Finkelstein, Marco Barbanti

September 13, 2014

News Industry News

Significant Patient Benefits With Edwards SAPIEN Valve Demonstrated In 5-Year PARTNER Trial Data

September 13, 2014

News Industry News

Clinical Trial Examines the Long Term Outcomes of a Self-Expanding Transcatheter Aortic Valve in Inoperable Patients with Aortic Stenosis

September 13, 2014

News Industry News

5 Year Data from Clinical Trial Studying TAVR in Patients with Severe Aortic Stenosis Demonstrates Persistent Mortality Benefit and Lower Rate of Repeat Hospitalizations Compared to Standard Therapy

September 13, 2014

News Conference News ESC 2014

Mitral Regurgitation Associated with Decreased Survival in TAVR Patients

Yael L. Maxwell

September 03, 2014

Advertisement

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Preexisting—But Not New-Onset—A-fib Predicts Worse Long-term Outcomes After TAVR

La FA Preexistente, No de Reciente Aparición, Predice Peores Resultados a Largo Plazo Post-TAVR

Preexisting Thrombocytopenia Worsens Complications After TAVR

La Trombocitopenia Preexistente Empeora las Complicaciones Post-TAVR

PARTNER Data Provide More Evidence of Mortality Impact of Post-TAVR Regurgitation

Datos del PARTNER ofrecen Más Evidencias del Impacto de la Mortalidad sobre la Regurgitación Post-TAVR

The Percutaneous Transfemoral Approach Is Preferred in Most Patients Case Selection, Technique, and Outcomes!

TCT 701: A Multidisciplinary, Multimodality but Minimalist (3M) Approach to Transfemoral Transcatheter Aortic Valve Replacement Facilitates Safe Next-Day Discharge Home in High-Risk Patients: 1-Year Follow-up

The Cost of TAVR: Association Between Length of Stay and the Cost of Transfemoral Transcatheter Aortic Valve Replacement in Medicare Patients

Landscape Highlights of New Transfemoral Access-Closure Devices

Capture Devices Hold Promise for Decreasing TAVR-Related Stroke

Case #2: Transfemoral TAVR for Bicuspid Aortic Valve Stenosis Using a Second-Generation Device

TCT Course Director Outlines Current TAVR Controversies

Registry Data Show Promise of Valve-in-Valve TAVR in High-Risk Patients

TCT 687: One-Year Outcomes of Transfemoral Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Intermediate Surgical Risk: The Italian OBSERVANT Study

Significant Patient Benefits With Edwards SAPIEN Valve Demonstrated In 5-Year PARTNER Trial Data

Clinical Trial Examines the Long Term Outcomes of a Self-Expanding Transcatheter Aortic Valve in Inoperable Patients with Aortic Stenosis

5 Year Data from Clinical Trial Studying TAVR in Patients with Severe Aortic Stenosis Demonstrates Persistent Mortality Benefit and Lower Rate of Repeat Hospitalizations Compared to Standard Therapy

Mitral Regurgitation Associated with Decreased Survival in TAVR Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content